Rai M, Ahlberg A, Marwell J, Chaudhary W, Savino 3rd J, Alter E
J Nucl Cardiol. 2016; 24(2):724-734.
PMID: 26902485
DOI: 10.1007/s12350-016-0448-9.
Liao P, Wang L, Guo L, Zeng R, Huang J, Zhang M
Evid Based Complement Alternat Med. 2015; 2015:646530.
PMID: 26451156
PMC: 4584225.
DOI: 10.1155/2015/646530.
Joy M
Br Med J (Clin Res Ed). 2010; 288(6413):339-40.
PMID: 20742166
PMC: 1444068.
DOI: 10.1136/bmj.288.6413.339.
Cantor W, Baptista S, Srinivas V, Pearte C, Menon V, Sadowski Z
Am Heart J. 2009; 157(4):666-72.
PMID: 19332193
PMC: 2744208.
DOI: 10.1016/j.ahj.2008.12.004.
Soofi M, Khan S
Ann Saudi Med. 2008; 28(5):371-3.
PMID: 18779638
PMC: 6074494.
DOI: 10.5144/0256-4947.2008.371.
Silent myocardial ischemia: recent developments.
Cohn P
Curr Atheroscler Rep. 2005; 7(2):155-63.
PMID: 15727732
DOI: 10.1007/s11883-005-0039-8.
Detection of multivessel disease post myocardial infarction using an exercise-induced QRS score.
Michaelides A, Papapetrou D, Aigyptiadou M, Psomadaki Z, Andrikopoulos G, Kartalis A
Ann Noninvasive Electrocardiol. 2004; 9(3):221-7.
PMID: 15245337
PMC: 6932144.
DOI: 10.1111/j.1542-474X.2004.93551.x.
An overview of coronary artery disease-1981.
Hall R
Cardiovasc Dis. 1981; 8(2):159-164.
PMID: 15216204
PMC: 287913.
Stress radionuclide myocardial perfusion imaging detects more residual ischemia than stress echocardiography following acute myocardial infarction.
Harris K, Nanna M, Srinivas V, Del Vecchio A, Gordon G, Sheehy M
Int J Cardiovasc Imaging. 2004; 20(2):145-54.
PMID: 15068146
DOI: 10.1023/b:caim.0000014102.88038.7c.
Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.
Mahmarian J, Dwivedi G, Lahiri T
J Nucl Cardiol. 2004; 11(2):186-209.
PMID: 15052250
DOI: 10.1016/j.nuclcard.2003.12.006.
Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction.
Lancellotti P, Benoit T, Rigo P, Pierard L
Heart. 2001; 86(5):510-5.
PMID: 11602542
PMC: 1729965.
DOI: 10.1136/heart.86.5.510.
Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT.
Candell-Riera J, Llevadot J, Santana C, Castell J, Aguade S, Armadans L
J Nucl Cardiol. 2001; 8(2):122-8.
PMID: 11295688
DOI: 10.1067/mnc.2001.109928.
Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme.
Dugmore L, Tipson R, Phillips M, Flint E, STENTIFORD N, Bone M
Heart. 1999; 81(4):359-66.
PMID: 10092561
PMC: 1729018.
DOI: 10.1136/hrt.81.4.359.
The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.
Beller G, Brown K
J Nucl Cardiol. 1998; 5(6):634-42.
PMID: 9869487
DOI: 10.1016/s1071-3581(98)90119-2.
Multicenter trial on prognostic value of inducible ischemia, assessed by dobutamine stress echocardiography and exercise electrocardiography test, in patients with uncomplicated myocardial infarction, treated with thrombolytic therapy.
Galati A, Bigi R, Coletta C, Fiorentini C, Ricci R, Occhi G
Int J Card Imaging. 1998; 14(3):155-62.
PMID: 9813751
DOI: 10.1023/a:1006061101594.
Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group.
Gosselink A, Liem A, Reiffers S, Zijlstra F
Clin Cardiol. 1998; 21(4):254-60.
PMID: 9562935
PMC: 6655906.
DOI: 10.1002/clc.4960210405.
Should all patients undergo cardiac catheterization after a myocardial infarction?.
Verani M
J Nucl Cardiol. 1994; 1(5 Pt 2):S134-46.
PMID: 9420739
DOI: 10.1007/BF03032559.
Predicting severe ischemic events after uncomplicated myocardial infarction by exercise testing and rest and exercise radionuclide ventriculography.
Mazzotta G, Camerini A, Scopinaro G, Villavecchia G, Lionetto R, Vecchio C
J Nucl Cardiol. 1994; 1(3):246-53.
PMID: 9420707
DOI: 10.1007/BF02940338.
Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.
Miller D, Stratmann H, Shaw L, Tamesis B, Wittry M, Younis L
J Nucl Cardiol. 1994; 1(1):72-82.
PMID: 9420673
DOI: 10.1007/BF02940014.
Dipyridamole thallium-201 scintigraphy for early risk stratification of patients after uncomplicated myocardial infarction.
Hung J, Moshiri M, Groom G, van der Schaaf A, PARSONS R, Hands M
Heart. 1997; 78(4):346-52.
PMID: 9404249
PMC: 1892252.
DOI: 10.1136/hrt.78.4.346.